Directory
>
Stephen Dilly
Stephen Dilly
Chief Executive Officer | Codexis, Inc.
San Francisco, California, United States
Stephen Dilly
Summary
Stephen Dilly is a seasoned executive in the pharmaceutical and biopharmaceutical sectors, currently serving as the CEO of Codexis. With a rich history of leadership roles across various organizations, he has demonstrated a strong commitment to innovation and strategic development in healthcare. His expertise spans drug development, clinical trials, and commercialization, making him a pivotal figure in advancing biotechnological solutions. Stephen has held multiple board positions, showcasing his ability to guide companies through complex challenges. His educational background in medicine and physiology from the University of London underpins his scientific acumen. Passionate about teamwork, he thrives in collaborative environments where he can work on meaningful projects. Stephen is also known for his deep interest in emerging technologies and their applications in healthcare. He continues to influence the industry with his visionary approach and dedication to improving patient outcomes.
Stephen Dilly
Work Experience
Chief Executive Officer at
Codexis, Inc.
August 2022 - Present
Board Member at
Cognoa
November 2018 - October 2024
Board Member at
Codexis, Inc.
April 2020 - September 2022
Chief Executive Officer at
Sierra Oncology, Inc.
May 2020 - July 2022
Board Member at
Adjuvance Technologies
September 2019 - March 2022
Chairman at
DNAtrix
June 2019 - January 2022
Independent Director at
Sangamo Therapeutics, Inc.
May 2010 - September 2020
Special Advisor at
Aimmune Therapeutics
July 2018 - June 2020
CEO at
Aimmune Therapeutics
April 2014 - June 2018
Chairman at
Allergen Research Corporation
March 2013 - April 2014
CEO at
Photothera, Inc.
January 2012 - December 2012
CEO at
APT Pharmaceuticals
May 2006 - December 2011
National Board of Advisors at
University of California, Davis
January 2001 - January 2010
Independent Director at
AVIGEN LIMITED
January 2007 - January 2009
CMO at
Chiron Biopharma
October 2003 - April 2006
VP Development Sciences at
Genentech
January 2002 - January 2003
VP Medical Affairs at
Genentech Foundation
January 1998 - January 2001
VP Neurosciences, VP CardioPulmonary etc at
GSK
January 1988 - January 1998
Stephen Dilly
Education
University of London, Bachelor Of Medicine, Bachelor Of Surgery (Mbbs), Phd, Bsc
January 1976 - January 1986
Frequently Asked Questions about Stephen Dilly
What is Stephen Dilly email address?
Stephen Dilly's primary email address is *************@codexis.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Stephen Dilly work for?
Stephen Dilly is a Chief Executive Officer at Codexis, Inc., a company specializing in Commercial physical research.
Where Stephen Dilly graduated from?
Stephen Dilly holds a degree in Medicine And Physiology from University of London.
How can I directly contact Stephen Dilly?
To contact Stephen Dilly directly, you can use the email address *************@codexis.com. Complete contact information is available upon registration with Muraena.
Who is Stephen Dilly?
Stephen Dilly is a seasoned executive in the pharmaceutical and biopharmaceutical sectors, currently serving as the CEO of Codexis. With a rich history of leadership roles across various organizations, he has demonstrated a strong commitment to innovation and strategic development in healthcare. His expertise spans drug development, clinical trials, and commercialization, making him a pivotal figure in advancing biotechnological solutions. Stephen has held multiple board positions, showcasing his ability to guide companies through complex challenges. His educational background in medicine and physiology from the University of London underpins his scientific acumen. Passionate about teamwork, he thrives in collaborative environments where he can work on meaningful projects. Stephen is also known for his deep interest in emerging technologies and their applications in healthcare. He continues to influence the industry with his visionary approach and dedication to improving patient outcomes.
Stephen`s contact details
*************@codexis.com
**@cognoa.com
Colleagues
Senior VP Pharmaceuticals
Member Board of Trustees
SVP and General Manager, Performance Enzymes
SVP, Technical Operations
Vice President, Corporate Law & Privacy Officer
Vice President Information Technology
Chief Financial Officer
President and CEO
Senior Vice President & Head of Human Resources
Chief Operating Officer